Physician profile
Daniel Penello
NPI 1851627475
$4,898.78
in general payments reported to CMS, 2019-2025
32 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $2,661 · 2021: $408 · 2022: $514 · 2023: $379 · 2024: $211 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $2,375.00 | 2020 | |
| Integra Lifesciences Corporation | $413.27 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Tenoglide |
| Stryker Corporation | $335.13 | 2019-2024 | Actishield, Prostep Mica, Augment Injectable |
| Globus Medical, INC. | $322.05 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $250.56 | 2019-2024 | Xiaflex |
| Smith+Nephew, INC. | $139.40 | 2019-2025 | Collagenase Santyl |
| Axogen | $128.38 | 2021-2023 | Avance Nerve Graft |
| Endo USA, INC. | $97.20 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $89.07 | 2020-2022 | |
| Orthofix Medical, INC. | $82.25 | 2019-2024 | Physio-Stim |
| Horizon Therapeutics Plc | $76.75 | 2021-2022 | |
| Organogenesis INC. | $72.55 | 2020 | |
| Dynasplint Systems INC. | $62.83 | 2019-2021 | |
| Mvp Orthopedics INC | $51.07 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $49.66 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $45.20 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $29.22 | 2019-2020 | |
| Kerecis Limited | $28.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $28.55 | 2021 | |
| Checkpoint Surgical, INC | $25.03 | 2024 | Checkpoint Stimulators |
| Biocircuit Technologies INC | $21.38 | 2025 | Nerve Tape |
| Triad Life Sciences INC. | $20.47 | 2022 | |
| Acumed LLC | $19.49 | 2022 | |
| Treace Medical Concepts, INC. | $18.67 | 2025 | |
| Linvatec Corporation | $18.46 | 2019 | |
| Sonex Health, INC. | $17.40 | 2021 | |
| Arthrosurface Incorporated | $16.75 | 2020 | |
| Bioventus LLC | $13.72 | 2022 | |
| Coastal Medical Technologies LLC | $13.51 | 2024 | |
| Paratek Pharmaceuticals, INC. | $13.38 | 2024 | Nuzyra |
| Fidia Pharma USA INC. | $13.00 | 2020 | |
| Zyla Life Sciences, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Penello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.